EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 4 (Avril 2009) Med Sci (Paris), 25 4 (2009) 361-369 References
Free Access
Issue
Med Sci (Paris)
Volume 25, Number 4, Avril 2009
Page(s) 361 - 369
Section M/S revues
DOI https://doi.org/10.1051/medsci/2009254361
Published online 15 April 2009
  1. Montreuil J, Tonnelat J, Mullet S. Preparation and properties of lactosiderophilin (lactotransferrin) of human milk. Biochim Biophys Acta 1960; 45 : 413–21. [Google Scholar]
  2. Baker EN, Baker HM, Kidd RD. Lactoferrin and transferrin : functional variations on a common structural framework. Biochem Cell Biol 2002; 80 : 27–34. [Google Scholar]
  3. Beaumont C. Mécanismes moléculaires de l’homéostasie du fer. Med Sci (Paris) 2004; 20 : 68–72. [Google Scholar]
  4. Masson PL, Heremans JF, Dive C. An ironbinding protein common to many external secretions. Clinica Chimica Acta 1966; 14 : 735–9. [Google Scholar]
  5. Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969; 130 : 643–58. [Google Scholar]
  6. Fillebeen C, Ruchoux MM, Mitchell V, et al. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 2001; 96 : 103–13. [Google Scholar]
  7. Anderson BF, Baker HM, Norris GE, et al. Structure of human lactoferrin : crystallographic structure analysis and refinement at 2.8 Å resolution. J Mol Biol 1989; 209 : 711–34. [Google Scholar]
  8. Baker EN, Baker HM. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 2009; 91 : 3–10. [Google Scholar]
  9. Legrand D, Pierce A, Elass E, et al. Lactoferrin structure and functions. Adv Exp Med Biol 2008; 606 : 163–94. [Google Scholar]
  10. Li Y, Limmon GV, Imani F, et al. Induction of lactoferrin gene expression by innate immune stimuli in mouse mammary epithelial HC-11 cells. Biochimie 2009; 91 : 58–67. [Google Scholar]
  11. Valenti P, Antonini G. Lactoferrin : an important host defence against microbial and viral attack. Cell Mol Life Sci 2005; 62 : 2576–87. [Google Scholar]
  12. Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie 2009; 91 : 19–29. [Google Scholar]
  13. Tomita M, Bellamy W, Takase M, et al. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1991; 74 : 4137–42. [Google Scholar]
  14. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin : a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005; 62 : 2588–98. [Google Scholar]
  15. Haney EF, Nazmi K, Lau F, et al. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie 2009; 91 : 141–54. [Google Scholar]
  16. Wu YM, Juo SH, Ho YP, et al. Association between lactoferrin gene polymorphisms and aggressive periodontitis among Taiwanese patients. J Periodontal Res 2008; 7 octobre (online). [Google Scholar]
  17. Thomassen EA, van Veen HA, van Berkel PH, et al. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res 2005; 14 : 397–405. [Google Scholar]
  18. Haridas M, Anderson BF, Baker EN. Structure of human diferric lactoferrin refined at 2.2 A resolution. Acta Crystallogr D Biol Crystallogr 1995; 51 : 629–46. [Google Scholar]
  19. Iwamaru Y, Shimizu Y, Imamura M, et al. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation. J Neurochem 2008; 107 : 636–46. [Google Scholar]
  20. Legrand D, Elass E, Carpentier M, et al. Lactoferrin : a modulator of immune and inflammatory responses. Cell Mol Life Sci 2005; 62 : 2549–59. [Google Scholar]
  21. Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin : a critical overview. Cell Mol Life Sci 2005; 62 : 2540–8. [Google Scholar]
  22. Konishi M, Iwasa M, Yamauchi K, et al. Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol Res 2006; 36 : 27–32. [Google Scholar]
  23. Tsuda H, Sekine K, Fujita K, et al. Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies. Biochem Cell Biol 2002; 80 : 131–6. [Google Scholar]
  24. Bezault J, Bhimani R, Wiprovnick J, et al. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994; 54 : 2310–2. [Google Scholar]
  25. Moore SA, Anderson BF, Groom CR, et al. Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution. J Mol Biol 1997; 274 : 222–36. [Google Scholar]
  26. Hwang PM, Zhou N, Shan X, et al. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 1998; 37 : 4288–98. [Google Scholar]
  27. Teng C, Gladwell W, Raphiou I, et al. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 2004; 17 : 317–23. [Google Scholar]
  28. Benaïssa M, Peyrat JP, Hornez L, et al. Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer 2005; 114 : 299–306. [Google Scholar]
  29. Mariller C, Benaïssa M, Hardiville S, et al. Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression. FEBS J 2007; 274 : 2038–53. [Google Scholar]
  30. Penco S, Scarfi S, Giovine M, et al. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 2001; 34 : 151–9. [Google Scholar]
  31. Son KN, Park J, Chung CK, et al. Human lactoferrin activates transcription of IL-1beta gene in mammalian cells. Biochem Biophys Res Commun 2002; 290 : 236–41. [Google Scholar]
  32. Mariller C, Hardiville S, Hoedt E, et al. Proteomic approach to the identification of novel delta-lactoferrin target genes : Characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie 2009; 91 : 109–22. [Google Scholar]
  33. Gallois A, Jurdic P. Ostéo-immunologie : une vision globale et intégrée du tissu squelettique et du système immunitaire. Med Sci (Paris) 2009; 25 : 259–65. [Google Scholar]
  34. Cornish J, Palmano K, Callon KE, et al. Lactoferrin and bone ; structure-activity relationships. Biochem Cell Biol 2006; 84 : 297–302. [Google Scholar]
  35. Sanchez L, Calvo M, Brock J. Biological role of lactoferrin. Arch Dis Child 1992; 67 : 657–61. [Google Scholar]
  36. Ward PP, Mendoza-Meneses M, Cunningham GA, et al. Iron status in mice carrying a targeted disruption of Lactoferrin, Mol Cell Biol 2003; 23 : 178–85. [Google Scholar]
  37. Suzuki YA, Lopez V, Lonnerdal B. Mammalian lactoferrin receptors : structure and function. Cell Mol Life Sci 2005; 62 : 2560–75. [Google Scholar]
  38. Paesano R, Pietropaoli M, Gessani S, et al. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie 2009; 91 : 44–51. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.